Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients
AuthorsD.D. Fraser et al.
JournalHeliyon
PubMed ID
'Critically ill patients infected with SARS-CoV-2 display adaptive immunity, but it is unknown if they develop cross-reactivity to variants of concern (VOCs). We profiled cross-immunity against SARS-CoV-2 VOCs in naturally infected, non-vaccinated, critically ill COVID-19 patients. Wave-1 patients (wild-type infection) were similar in demographics to Wave-3 patients (wild-type/alpha infection), but ... More